In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neurostimulation device maker Neuronetics gets $30mm in D round

Executive Summary

First-time investor New Leaf Venture Partners led a $30mm Series D financing for Neuronetics (neuromodulation devices) and adds a board member to the company. The round, which could still bring in another $458k according to the Form D, was done by 17 investors including returning shareholders Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, InterWest Partners, and KBL Healthcare Ventures.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies